Health and Family Welfare Government Departments Closing in 9 days TDR #55751412

Tender For T.E.NO.GMSCL/D-789/RC/2026-27 T.E.NO.GMSCL/D-789/RC/2026-27- albendazole oral suspension 200 mg/5 ml, betamethasone valerate cream 0.05 percent, oral liquid chloroquine phosphate 50 mg/5 ml, cholecalciferol granules (vitamin d3), 60,000 i.

Issued by Government Departments · Gandhinagar, Gujarat
Tender Value
Ref. Documents
Estimated cost
Bid Submission
30 Jul 2026
9 days left
EMD
Ref. Documents
Bank guarantee accepted
Document Fee
17700
Non-refundable
Tender Type
Online

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
Gandhinagar → Gujarat
EMD Exemption
Not Available
Quantity
Not Available

Project Description

T.E.NO.GMSCL/D-789/RC/2026-27- albendazole oral suspension 200 mg/5 ml, betamethasone valerate cream 0.05 percent, oral liquid chloroquine phosphate 50 mg/5 ml, cholecalciferol granules (vitamin d3), 60,000 i.u., ciprofloxacin ophthalmic solution 0.3 percent w/v, clotrimazole cream 1percent, syrup dextromethorphan 13.5 mg/ 5 ml, dicyclomine oral solution 10 mg/5ml, domperidone suspension 1 mg/ml, metronidazole benzoate oral suspension 100 mg/5 ml, 60 ml bottle, miconazole cream 2 percentage, 15 gm tube, oral rehydration salts (o.r.s) .(w.h.o. formula), 20.5 gm sachet, paracetamol syrup 125 mg/5 ml- oral liquid, syrup/oral liquid salbutamol 2 mg/5 ml, silver sulphadiazine cream 1percent (500 gm), timolol maleate eye drops 0.5percent, 5 ml vial, trimethoprim & sulphamethoxazole oral suspension, 50 ml bottle, calamine lotion, clotrimazole lotion 1percent, povidone iodine ointment 5 percent, silver sulphadiazine cream 1percent (20 gm), azithromycin oral suspension 200 mg/5 ml, clobetasol propionate cream 0.05 percent, syrup levocetirizine 2.5 mg/5 ml, lactulose solution 3.335 gm/5 ml, magnesium sulphate powder, cyclopentolate eye drops 1percent w/v,5 ml vial, moxifloxacine eye drops 0.5percent w/v, prednisolone acetate eye drop 1percent w/v, brimonidine tartrate and timolol eye drops 0.15percent w/v + 0.5percent w/v (5 ml vial), xylometazoline nasal drops 0.10 percent, moxifloxacin 0.5percent+ dexamethasone 0.1percent eye drops (preservative free), natamycin (5percent) eye drops, travoprost eye drops 0.004percent, carboxy methyl cellulose 1percentliquigel, fluticasone 0.05 percent w/w cream, feracrylum gel 1 percent w/w, 15 gm tube, haemorrhoidal cream‐ beclomethasone dipropionate 0.025percent, phenyleherine hydrochloride 0.1percent , lignocaine hydrochloride 2.5percent

Corrigendum

Sr No Corrigendum Date Corrigendum Type New Submission Date
1 N/A 30-Jun-2026
2 N/A 15-Jul-2026
3 N/A 15-Jun-2026
4 N/A 30-Jul-2026

BOQ

Sl. No. Item Name
1albendazole oral suspension 200 mg/5 ml
2Betamethasone Valerate Cream 0.05 percent
3Oral Liquid Chloroquine Phosphate 50 mg/5 ml
4Cholecalciferol Granules (Vitamin D3), 60,000 I.U.
5Ciprofloxacin Ophthalmic Solution 0.3 percent w/v
6Clotrimazole Cream 1percent
7Syrup Dextromethorphan 13.5 mg/ 5 ml
8Dicyclomine Oral Solution 10 mg/5ml
9Domperidone Suspension 1 mg/ml
10Metronidazole Benzoate Oral Suspension 100 mg/5 ml, 60 ml Bottle
11Miconazole Cream 2 Percentage, 15 gm Tube
12Oral Rehydration Salts (O.R.S) .(W.H.O. Formula), 20.5 Gm Sachet
13Paracetamol Syrup 125 mg/5 ml- Oral Liquid
14Syrup/Oral liquid Salbutamol 2 mg/5 ml
15Silver Sulphadiazine Cream 1percent (500 gm)
16Timolol Maleate Eye Drops 0.5percent, 5 ml vial
17Trimethoprim & Sulphamethoxazole Oral Suspension, 50 ml bottle
18Calamine Lotion
19Clotrimazole Lotion 1percent
20Povidone Iodine Ointment 5 percent
21Silver Sulphadiazine Cream 1percent (20 gm)
22Azithromycin Oral Suspension 200 mg/5 ml
23Clobetasol Propionate Cream 0.05 percent
24Syrup Levocetirizine 2.5 mg/5 ml
25Lactulose Solution 3.335 gm/5 ml
26Magnesium Sulphate Powder
27Cyclopentolate Eye drops 1percent w/v,5 ml vial
28Moxifloxacine Eye Drops 0.5percent w/v
29Prednisolone Acetate Eye Drop 1percent w/v
30Brimonidine Tartrate and Timolol Eye Drops 0.15percent w/v + 0.5percent w/v (5 ml Vial)
31Xylometazoline Nasal Drops 0.10 percent
32Moxifloxacin 0.5percent+ Dexamethasone 0.1percent Eye Drops (Preservative Free)
33Natamycin (5percent) Eye Drops
34Travoprost Eye Drops 0.004percent
35Carboxy Methyl Cellulose 1percentLiquigel
36Fluticasone 0.05 percent w/w Cream
37Feracrylum Gel 1 percent w/w, 15 gm tube
38Haemorrhoidal Cream‐ Beclomethasone Dipropionate 0.025percent, Phenyleherine Hydrochloride 0.1percent , Lignocaine Hydrochloride 2.5percent

AI Tender Summary

OUR REF NO 55751412
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 30-07-2026
Authority
Authority Name Gujarat Medical Services Corporation Limited
Work Description T.E.NO.GMSCL/D-789/RC/2026-27- albendazole oral suspension 200 mg/5 ml, betamethasone valerate cream 0.05 percent, oral liquid chloroquine phosphate 50 mg/5 ml, cholecalciferol granules (vitamin d3), 60,000 i.u., ciprofloxacin ophthalmic solution 0.3 percent w/v, clotrimazole cream 1percent, syrup dextromethorphan 13.5 mg/ 5 ml, dicyclomine oral solution 10 mg/5ml, domperidone suspension 1 mg/ml, metronidazole benzoate oral suspension 100 mg/5 ml, 60 ml bottle, miconazole cream 2 percentage, 15 gm tube, oral rehydration salts (o.r.s) .(w.h.o. formula), 20.5 gm sachet, paracetamol syrup 125 mg/5 ml- oral liquid, syrup/oral liquid salbutamol 2 mg/5 ml, silver sulphadiazine cream 1percent (500 gm), timolol maleate eye drops 0.5percent, 5 ml vial, trimethoprim & sulphamethoxazole oral suspension, 50 ml bottle, calamine lotion, clotrimazole lotion 1percent, povidone iodine ointment 5 percent, silver sulphadiazine cream 1percent (20 gm), azithromycin oral suspension 200 mg/5 ml, clobetasol propionate cream 0.05 percent, syrup levocetirizine 2.5 mg/5 ml, lactulose solution 3.335 gm/5 ml, magnesium sulphate powder, cyclopentolate eye drops 1percent w/v,5 ml vial, moxifloxacine eye drops 0.5percent w/v, prednisolone acetate eye drop 1percent w/v, brimonidine tartrate and timolol eye drops 0.15percent w/v + 0.5percent w/v (5 ml vial), xylometazoline nasal drops 0.10 percent, moxifloxacin 0.5percent+ dexamethasone 0.1percent eye drops (preservative free), natamycin (5percent) eye drops, travoprost eye drops 0.004percent, carboxy methyl cellulose 1percentliquigel, fluticasone 0.05 percent w/w cream, feracrylum gel 1 percent w/w, 15 gm tube, haemorrhoidal cream‐ beclomethasone dipropionate 0.025percent, phenyleherine hydrochloride 0.1percent , lignocaine hydrochloride 2.5percent
Basic Detail
Tender No T.E.NO.GMSCL/D-789/RC/2026-27
Bidding Type Tender
Location
City Gandhinagar
State Gujarat
Key Dates
Publish Date 01 Jan 0001
Submission Date 30 Jul 2026
Open Date 01 Jan 0001
Finance
Tender Value Ref. Documents
Tender Fee 17700
EMD Ref. Documents
Exemption Not Available
Document List
AgreementandBankGuarantee15.pdf
DebarmentPolicy19.pdf
e24f6498166a4e3e9594031d88d475f0.html
GRlistofbank20261.pdf
RateContractTermsandCondition15.pdf
TenderDocumentD78930.05.2026.pdf
TenderNoticeD78930.06.2026.pdf
TenderScheduleD78938ItemMisc.pdf

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Jul 21, 2026
11:30 IST

Tender Published

Tender notice published.

Today
Jun 30, 2026
18:00 IST

Corrigendum-1 Issued

Clarifications on tender conditions and amendments issued.

Completed
Jul 15, 2026
18:00 IST

Corrigendum-2 Issued

Clarifications on tender conditions and amendments issued.

Completed
Jun 15, 2026
18:00 IST

Corrigendum-3 Issued

Clarifications on tender conditions and amendments issued.

Completed
Jul 30, 2026
18:00 IST

Corrigendum-4 Issued

Clarifications on tender conditions and amendments issued.

Upcoming · 9 days
Jul 30, 2026
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Upcoming · 9 days

Tender Documents

Download All (ZIP) ↓
pdf

AgreementandBankGuarantee15.pdf

pdf

DebarmentPolicy19.pdf

html

e24f6498166a4e3e9594031d88d475f0.html

pdf

GRlistofbank20261.pdf

pdf

RateContractTermsandCondition15.pdf

05

TenderDocumentD78930.05.2026.pdf

06

TenderNoticeD78930.06.2026.pdf

pdf

TenderScheduleD78938ItemMisc.pdf

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders